NovoCure LimitedNVCRNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank92
3Y CAGR+10.9%
5Y CAGR+13.1%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+10.9%/yr
vs +19.3%/yr prior
5Y CAGR
+13.1%/yr
Consistent
Acceleration
-8.4pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$417.73M-2.6%
2024$428.89M+9.7%
2023$390.87M+27.6%
2022$306.41M+16.4%
2021$263.18M+16.7%
2020$225.45M+22.1%
2019$184.62M+22.2%
2018$151.12M+23.2%
2017$122.64M+11.0%
2016$110.46M-